April 1, 2016 11:59am
You need it; you want it, you have to have it … to keep up with the constant comings and goings of the stem, cell and gene therapy and regenerative medicine sector news, opinion and share pricing!
Exclusivity is now here!
Starting April 1, 2016 access to RegMed Investors’ targeted content will be by subscription only.
As an appreciation to my most valued readers, I am offering 20% off <$800> the regular price of $1000 for one full year of RegMed Investors - a $200 savings upon paying upfront!
I cut through the hyperbole and parse the news to deliver relevant facts and quality analysis on how they affect (or should affect) pricing; allowing you to stay in the “know”, save and enhance your portfolio.
Pricing “location” can be triangulated by interpretive insight, content clarity, and demanding honest answers to tough questions. Together these support RegMed Investors’ total commitment to looking out solely for the benefit of investors.
I’ve spent years correlating actionable news, the pricing of opportunity, the fluctuation of metrics, timing and strengths of the stem, cell and gene therapy sector in the regenerative medicine universe!
To continue receiving meaningful analysis for smart investing in the SCGT&RM sector, subscribe now to RegMed Investors…simply click the button below to get started … http://www.regmedinvestors.com/create-account